Skip to main content
SpringerLink
Log in

Clozapine and Prevention of Suicide in Schizophrenia

A Viewpoint by Robert Kerwin

  • Adis Drug Profile
  • Guest Commentary
  • Published:
CNS Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Walker AM, Lanza LL, Arellano F, et al. Mortality in current and former users of clozapine. Epidemiology 1997 Nov; 8(6): 671–7

    PubMed  CAS  Google Scholar 

  2. Munro J, O’Sullivan D, Andrews C, et al. Active monitoring of 12760 clozapine recipients in the UK and Ireland: beyond pharmacovigilance. Br J Psychiatry 1999 Dec; 175: 576–80

    Article  PubMed  CAS  Google Scholar 

  3. Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT). Arch Gen Psychiatry 2003; 60: 82–91

    Article  PubMed  CAS  Google Scholar 

  4. Committee on Safety of Medicines. London, 2003. (Data on file)

Download references

Author information

Authors and Affiliations

  1. Department of Psychological Medicine, Institute of Psychiatry, London, England

    Robert Kerwin

Authors
  1. Robert Kerwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kerwin, R. Clozapine and Prevention of Suicide in Schizophrenia. CNS Drugs 17, 281–283 (2003). https://doi.org/10.2165/00023210-200317040-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-200317040-00007

Search

Navigation